Chemical Structure : HIF-2α inhibitor AT-1
Catalog No.: PC-25845Not For Human Use, Lab Use Only.
HIF-2α inhibitor AT-1 is a small molecule hypoxia-inducible factor 2-alpha (HIF-2α) agonist with EC50 of 1.84 uM and Emax=233%, binds to HIF-2α-PAS-B domain with ITC KD of 2.63 uM.
Bulk size, bulk discount!
Welcome credit card payment!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
HIF-2α inhibitor AT-1 is a small molecule hypoxia-inducible factor 2-alpha (HIF-2α) agonist with EC50 of 1.84 uM and Emax=233%, binds to HIF-2α-PAS-B domain with ITC KD of 2.63 uM.
AT-1 binds to HIF-2α-PAS-B with rapid association and dissociation, yielding a KD of 3.60 μM for binding kinetics and 3.20 μM for affinity in SPR assays.
AT-1 (10-40 uM) activates HIF-2α signaling in 786-O and Hep3B cells, upregulates the expression of HIF-2α target genes, including VEGFA, EPO, and SERPINE1 (PAI-1).
AT-1 significantly promotes EPO secretion in Hep3B cells.
AT-1 (10 μM or 50 μM) exhibits anemia-ameliorating potential in doxorubicin-induced zebrafish anemia mode, shows a potential synergistic effect with PHD inhibitor Molidustat.
AT-1 potentiates the therapeutic efficacy of Molidustat in adenine-induced CKD anemia mouse model.
| M.Wt | 336.41 | |
| Formula | C19H16N2O2S | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
1. Chu SQ, et al. Acta Pharmacol Sin. 2025 Oct 1. doi: 10.1038/s41401-025-01657-w.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright